CGEM
Cullinan TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CGEM vs peer average
31/100
CGEM vs. peer average (F vs. D)
Grade spread
B 1 · C 3 · D 3 · F 3
Graded peers loaded
Coverage
10 graded
91% of tracked
Peer overview
JANX is the first available peer comparator.
Closest listed peer of the set for event-driven clinical-stage immunotherapy valuation; still not a direct indication match, but useful for comparing T-cell-engager sentiment and binary data-readout risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CGEM
Cullinan Therapeutics
JANX
Janux Therapeutics
Grade
F
C
Momentum
92
91
Value
41
41
Sentiment
23
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs JANX
CGEM / JANX
Grade Position
Below peers
CGEM vs. peer average (F vs. D)
31/100
Momentum
92
CGEMValue
41
CGEMSentiment
23
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CGEM
JANX is the first peer returned for this comparison set.